Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Devices & Dosimetry

Comparison of the Effects of Four Laser Wavelengths on Medication-Related Osteonecrosis of the Jaw (MRONJ) in a Murine Model: An In Vivo Photobiomodulation Study

The combined use of lasers at 660nm and 808nm wavelengths may yield successful results in treating MRONJ.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors studied rats with an induced model of medication-related osteonecrosis of the jaw and compared four laser wavelengths (405, 445, 660 and 808 nm). They report that new bone formation was higher in all laser groups than in the sham and control groups, and that 660 nm and 808 nm increased serum vitamin D and gave the best clinical, bone and histological outcomes. The study was conducted in a murine model with eight rats per group, so the findings may not apply to people.

Who or what was studied
Rats (murine model) with induced medication-related osteonecrosis of the jaw; eight rats per group across six groups
Wavelengths
405, 445, 660, 808 nm
Limits stated in the abstract
The study used a small animal model with eight rats per group, and the abstract does not address whether results would apply to humans.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Background

This study aims to investigate the effectiveness of lasers at various wavelengths in treating medication-related osteonecrosis of the jaw (MRONJ) using biochemical, clinical scoring, micro CT analysis, and histopathological methods. The study follows the ARRIVE guidelines to ensure robust and transparent research.

Methods

In our study, there were 6 groups, including one SHAM group, one CONTROL group, and four experimental groups, with 8 rats in each individual group. Each rat received antiresorptive drug intraperitoneally for 4 weeks and then had the left second molar in the mandible extracted. All animals were sacrificed at the end of the 12th week. In the experimental groups, lasers at wavelengths of 405nm, 445nm, 660nm, and 808nm were applied to the animals. Parameters such as serum vitamin D levels, bone density and bone volume at the extraction site, new bone formation, dead bone count, inflammatory cell count, and epithelial regeneration were examined. Additionally, clinical scoring was conducted after sacrifice. The laser parameters included power density, area, time, fluence, and mode (continuous wave), and the light was administered using a fiber with a Gaussian profile. Statistical analyses were performed with the NCSS (Number Cruncher Statistical System) 2007 Statistical Software (Utah, USA) package program. The results were evaluated at the p<0.05 significance level.

Results

According to the results obtained from our study, new bone formation in all experimental groups was significantly higher than in the SHAM and CONTROL groups. Furthermore, the 660nm and 808nm wavelengths increased serum vitamin D levels significantly. The most successful outcomes were observed in clinical scoring, dead bone count, epithelial cell regeneration, and bone density in the 660nm and 808nm wavelength groups.

Conclusions

The combined use of lasers at 660nm and 808nm wavelengths may yield successful results in treating MRONJ.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
405nm, 445nm, 660nm, 808nm

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Laser, Photobiomodulation, Sham, Control group, Wavelength, Fluence. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies